Data updated: Mar 10, 2026
MPI INDIUM DTPA IN 111
INDIUM IN-111 PENTETATE DISODIUM Radiopharmaceutical Activity
Approved 1982-02-18
1
Indication
--
Phase 3 Trials
44
Years on Market
Details
- Status
- Prescription
- First Approved
- 1982-02-18
- Routes
- INTRATHECAL
- Dosage Forms
- INJECTABLE
MPI INDIUM DTPA IN 111 Approval History
Loading approval history...
What MPI INDIUM DTPA IN 111 Treats
1 FDA approvalsOriginally approved for its first indication in 1982 .
- Other (1)
Other
(1 approval)- • Approved indication (Feb 1982)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
MPI INDIUM DTPA IN 111 FDA Label Details
ProIndications & Usage
Pentetate Indium Disodium In 111 is recommended for use in radionuclide cisternography.
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.